Passa al contenuto
Merck
Tutte le immagini(2)

Key Documents

GF83505742

Thulium

foil, not light tested, 50x50mm, thickness 0.025mm, as rolled, 99%

Sinonimo/i:

Thulium, TM000200

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula empirica (notazione di Hill):
Tm
Numero CAS:
Peso molecolare:
168.93
Numero MDL:
Codice UNSPSC:
12141615
ID PubChem:
NACRES:
NA.23

Saggio

99%

Forma fisica

foil

Produttore/marchio commerciale

Goodfellow 835-057-42

Resistività

90 μΩ-cm, 20°C

Misura × spessore

50 x 50 mm × 0.025 mm

P. eboll.

1950 °C (lit.)

Punto di fusione

1545 °C (lit.)

Densità

9.332 g/mL at 25 °C (lit.)

Stringa SMILE

[Tm]

InChI

1S/Tm
FRNOGLGSGLTDKL-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

For updated SDS information please visit www.goodfellow.com.

Note legali

Product of Goodfellow

Codice della classe di stoccaggio

13 - Non Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Kun Tang et al.
Journal of endourology, 28(1), 65-72 (2013-08-29)
To assess the efficacy and safety of thulium laser resection of the prostate (TmLRP) vs transurethral resection of the prostate (TURP) for treating patients with benign prostatic hyperplasia (BPH). A systematic search of the electronic databases, including Medline, Scopus, China
Amedeo Calisto et al.
Journal of neurosurgery. Pediatrics, 14(6), 563-572 (2014-10-18)
Hypothalamic hamartomas (HH) may induce drug-resistant epilepsy (DRE), thereby requiring surgical treatment. Conventionally, treatment is aimed at removing the lesion, but a disconnection procedure has been shown to be safer and at least as effective. The thulium laser (Revolix) has
T Bach et al.
World journal of urology, 28(2), 163-168 (2010-03-06)
Tm:YAG 2 mum cw laser prostatectomy was introduced in the treatment of benign ptostatic obstruction (BPO). Since then numerous studies have been published proving efficacy during follow-up. However, different surgical techniques were introduced with different names for similar techniques that
Li Li et al.
Journal of nanoscience and nanotechnology, 14(6), 4313-4319 (2014-04-18)
Lutetium oxide nanocrystals codoped with Tm3+ and Yb3+ have been successfully synthesized via adjusting the pH values of the precursor solution in a hydrothermal method followed by a subsequent calcination process. The samples were systematically characterized by X-ray diffraction, field-emission
Giovanni Muto et al.
Urology, 83(4), 851-855 (2014-02-20)
To determine whether thulium:yttrium-aluminum-garnet laser resection of bladder tumor (TmLRBT) may offer advantages over classic resection. From April 2011 to September 2012, 55 consecutive patients newly diagnosed with clinical stage ≤T2 bladder cancer were enrolled in a prospective study on TmLRBT.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.